Citigroup
NVRO

Citigroup’s NEVRO CORP. NVRO Stock Holding History

Citigroup’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,200
Closed -$585K – 7671
2020
Q3 		$585K Sell
4,200
-700
-14% -$93.5K ﹤0.01% 3720
2020
Q2 		$585K Sell
4,900
-800
-14% -$94.9K ﹤0.01% 4088
2020
Q1 		$570K Sell
5,700
-1,700
-23% -$204K ﹤0.01% 3753
2019
Q4 		$870K Sell
7,400
-3,000
-29% -$297K ﹤0.01% 3908
2019
Q3 		$894K Sell
10,400
-51,300
-83% -$3.88M ﹤0.01% 3772
2019
Q2 		$4M Sell
61,700
-28,200
-31% -$1.76M ﹤0.01% 2167
2019
Q1 		$5.62M Buy
89,900
+81,000
+910% +$3.81M 0.01% 1684
2018
Q4 		$346K Buy
8,900
+8,000
+889% +$356K ﹤0.01% 4502
2018
Q3 		$51K Buy
+900
New +$56.3K ﹤0.01% 6511

Other funds holding NVRO

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citigroup's NVRO Position: Q2 2025 in Review

Citigroup sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 26,134 shares — an estimated $153K sold.

Citigroup first reported a position in NVRO in Q4 2014 and held it in 42 quarters. The position peaked at $4.42M in Q4 2020. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Citigroup reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Citigroup sold 26,134 NEVRO CORP. shares in Q2 2025, an estimated $153K.
  • Citigroup first reported a position in NEVRO CORP. in Q4 2014 and held it in 42 quarters.
  • Citigroup's NEVRO CORP. position peaked at $4.42M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.